A Trial to Assess the Antipsychotic Efficacy of ITI-007
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 3/11/2017 |
| Start Date: | November 2014 |
| End Date: | September 2015 |
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 in Patients With Schizophrenia
The study will be conducted as a randomized, double-blind, parallel-group,
placebo-controlled, multi-center study in patients diagnosed with schizophrenia having an
acute exacerbation of psychosis.
placebo-controlled, multi-center study in patients diagnosed with schizophrenia having an
acute exacerbation of psychosis.
Inclusion Criteria:
- male or female subjects of any race, ages 18-60 inclusive, with a clinical diagnosis
of schizophrenia
- experiencing an acute exacerbation of psychosis
Exclusion Criteria:
- any subject unable to provide informed consent
- any female subject who is pregnant or breast-feeding
- any subject judged to be medically inappropriate for study participation
We found this trial at
1
site
Click here to add this to my saved trials
